Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2022	Mar. 31, 2021
Current assets:
Cash and cash equivalents	$ 33,435	$ 9,500
Restricted cash	500	0
Accounts receivable, net, including $1.2 million and $507 thousand from related parties as of March 31, 2022 and March 31, 2021, respectively	2,558	1,618
Inventory	6,330	2,223
Prepaid expenses and other current assets	1,971	953
Total current assets	44,794	14,294
Property and equipment, net	1,649	1,360
Goodwill	1,180	1,302
Intangible assets, net	617	914
Investment in joint venture	143	0
Other assets	263	274
Total assets	48,646	18,144
Current liabilities:
Accounts payable and accrued expenses	3,588	3,140
Deferred revenue	346	505
Development loan	0	10,000
Revolving credit facility, including accrued interest	180	10,150
Unfunded commitment to joint venture	0	1,866
Accrued payroll and benefits	1,171	1,410
Total current liabilities	5,285	27,071
Revolving credit facility	12,000	0
Promissory note	0	16,128
Total liabilities	17,285	43,199
Commitments and contingencies (Note 10)
Stockholders’ equity (deficit):
Common stock, $0.0001 par value; 750,000,000 shares authorized as of March 31, 2022 and March 31, 2021, and 53,379,307 and 40,531,996 shares issued and outstanding as of March 31, 2022 and March 31, 2021, respectively	5	4
Additional paid-in capital	211,190	144,201
Accumulated deficit	(178,638)	(168,403)
Accumulated other comprehensive loss	(1,196)	(857)
Total stockholders’ equity (deficit)	31,361	(25,055)
Total liabilities and stockholders’ equity (deficit)	$ 48,646	$ 18,144